Karine Goraj, PhD
Chief Scientific Officer
Karine is appointed as CSO of Amyl Therapeutics at the initiation of the Company (April 2021).
She is in charge of the Research and Development management, to lead internal research activities and scientific partnerships covering preclinical and development project phases.
Before to join Amyl, Karine worked in the RD department of GSK Vaccines more than 20 years and held several positions as Vaccine Project Leader as well as Head of Discovery Performance Unit of the GSK RD Center based in Italy.
Karine holds a PhD in Biochemistry from the Liege University, focusing her research to the field of Protein Engineering and Design as Professor Assistant during several years before to join GSK.